|Date||Name of the fair||Location|
|06.- 07.03.2019||Mikrobiom Kongress||Taiwan|
|16.- 19.04.2019||Microbiome Conference||Boston|
|07.05.2019||Swiss Biotech Day 2019||Basel|
|05. -07.11.2019||CPHL Europe||Frankfurt|
|31. -10.11.2019||World of Microbiome||Mailand|
|03. -05.12.2019||FI Europe||Paris|
|25. -26.09.2019||Vitafoods Asia||Singapur|
|31.10. -02.11.2019||World of Microbiome||Mailand|
We produce rare monosaccharides such as L-fucose and sialic acid and provide an extensive portfolio of HMOs. In particular 2'- fucosyllactose and 3'- fucosyllactose.
From the very beginning, we have focused on human milk oligosaccharides (HMOs). Although HMOs occur naturally in human milk, economical processes for the large-scale production of food-grade HMOs were not available when we launched the company in 2005. We set out to produce these molecules in very large quantities at a low cost and to manufacture food-grade quality products for use as functional food ingredients in infant formula.
During the last decade we have become a technology driver and we now partner well-known brands and international companies for the development and production of HMOs for the nutrition industry, as well as medical and scientific applications.
Get in touch!
If you would like to visit us at our booth, please don’t hesitate to contact us: